Patents by Inventor John Gaudette

John Gaudette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fusogenic compounds for delivery of biologically active molecules
    Patent number: 11413243
    Abstract: This invention includes fusogenic compounds, and compositions and methods of use thereof. The fusogenic compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, this invention relates to compounds, compositions and methods for providing nanoparticles to incorporate or encapsulate active agents, to deliver and distribute the active agents to cells, tissues, organs, and subjects.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: August 16, 2022
    Assignee: Nitto Denko Corporation
    Inventors: Kwok Yin Tsang, Bharat Majeti, John Gaudette, Roger Adami, Hao Bai, Wenbin Ying
  • IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF
    Publication number: 20220242820
    Abstract: Ionizable compounds, and compositions and methods of use thereof. The ionizable compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, the compounds, compositions and methods are to provide nanoparticles to encapsulate active agents, such as nucleic acid agents, and to deliver and distribute the active agents to cells, tissues, organs, and subjects.
    Type: Application
    Filed: April 5, 2022
    Publication date: August 4, 2022
    Inventors: Roger Adami, Hao Bai, John Gaudette, Bharat Majeti, Seiji Nukui, Kwok Yin Tsang, Hai Wang, Haiqing Yin, Wenbin Ying
  • FUSOGENIC COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES
    Publication number: 20220233445
    Abstract: Fusogenic compounds, and compositions and methods of use thereof. The fusogenic compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, compounds, compositions and methods are to provide nanoparticles to incorporate or encapsulate active agents, to deliver and distribute the active agents to cells, tissues, organs, and subjects.
    Type: Application
    Filed: April 5, 2022
    Publication date: July 28, 2022
    Inventors: Kwok Yin Tsang, Bharat Majeti, John Gaudette, Roger Adami, Hao Bai, Wenbin Ying
  • Ionizable compounds and compositions and uses thereof
    Patent number: 11384051
    Abstract: This invention includes ionizable compounds, and compositions and methods of use thereof. The ionizable compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, this invention relates to compounds, compositions and methods for providing nanoparticles to encapsulate active agents, such as nucleic acid agents, and to deliver and distribute the active agents to cells, tissues, organs, and subjects.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: July 12, 2022
    Assignee: Nitto Denko Corporation
    Inventors: Roger Adami, Hao Bai, John Gaudette, Bharat Majeti, Seiji Nukui, Kwok Yin Tsang, Hai Wang, Haiqing Yin, Wenbin Ying
  • Fusogenic compounds for delivery of biologically active molecules
    Patent number: 11364200
    Abstract: This invention includes fusogenic compounds, and compositions and methods of use thereof. The fusogenic compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, this invention relates to compounds, compositions and methods for providing nanoparticles to incorporate or encapsulate active agents, to deliver and distribute the active agents to cells, tissues, organs, and subjects.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: June 21, 2022
    Assignee: Nitto Denko Corporation
    Inventors: Kwok Yin Tsang, Bharat Majeti, John Gaudette, Roger Adami, Hao Bai, Wenbin Ying
  • Fusogenic compounds for delivery of biologically active molecules
    Patent number: 11318099
    Abstract: This invention includes fusogenic compounds, and compositions and methods of use thereof. The fusogenic compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, this invention relates to compounds, compositions and methods for providing nanoparticles to incorporate or encapsulate active agents, to deliver and distribute the active agents to cells, tissues, organs, and subjects.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: May 3, 2022
    Assignee: Nitto Denko Corporation
    Inventors: Kwok Yin Tsang, Bharat Majeti, John Gaudette, Roger Adami, Hao Bai, Wenbin Ying
  • FUSOGENIC COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES
    Publication number: 20190133948
    Abstract: This invention includes fusogenic compounds, and compositions and methods of use thereof. The fusogenic compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, this invention relates to compounds, compositions and methods for providing nanoparticles to incorporate or encapsulate active agents, to deliver and distribute the active agents to cells, tissues, organs, and subjects.
    Type: Application
    Filed: November 6, 2018
    Publication date: May 9, 2019
    Inventors: Kwok Tsang, Bharat Majeti, John Gaudette, Roger Adami, Hao Bai, Wenbin Ying
  • IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF
    Publication number: 20190127318
    Abstract: This invention includes ionizable compounds, and compositions and methods of use thereof. The ionizable compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, this invention relates to compounds, compositions and methods for providing nanoparticles to encapsulate active agents, such as nucleic acid agents, and to deliver and distribute the active agents to cells, tissues, organs, and subjects.
    Type: Application
    Filed: December 20, 2018
    Publication date: May 2, 2019
    Inventors: Roger Adami, Hao Bai, John Gaudette, Bharat Majeti, Seiji Nukui, Kwok Yin Tsang, Hai Wang, Haiqing Yin, Wenbin Ying
  • Ionizable compounds and compositions and uses thereof
    Patent number: 10167253
    Abstract: This invention includes ionizable compounds, and compositions and methods of use thereof. The ionizable compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, this invention relates to compounds, compositions and methods for providing nanoparticles to encapsulate active agents, such as nucleic acid agents, and to deliver and distribute the active agents to cells, tissues, organs, and subjects.
    Type: Grant
    Filed: June 23, 2016
    Date of Patent: January 1, 2019
    Assignee: Nitto Denko Corporation
    Inventors: Roger Adami, Hao Bai, John Gaudette, Bharat Majeti, Seiji Nukui, Kwok Yin Tsang, Hai Wang, Haiqing Yin, Wenbin Ying
  • IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF
    Publication number: 20160376229
    Abstract: This invention includes ionizable compounds, and compositions and methods of use thereof. The ionizable compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, this invention relates to compounds, compositions and methods for providing nanoparticles to encapsulate active agents, such as nucleic acid agents, and to deliver and distribute the active agents to cells, tissues, organs, and subjects.
    Type: Application
    Filed: June 23, 2016
    Publication date: December 29, 2016
    Inventors: Roger Adami, Hao Bai, John Gaudette, Bharat Majeti, Seiji Nukui, Kwok Yin Tsang, Hai Wang, Haiqing Ying, Wenbin Ying